OBREDON (NOVOTEC PHARMA LLC)


Welcome to the PulseAid listing for the OBREDON drug offered from NOVOTEC PHARMA LLC. This Opioid Agonist [EPC],Opioid Agonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: NOVOTEC PHARMA LLC
NON-PROPRIETARY NAME: Hydrocodone Bitartrate and Guaifenesin
SUBSTANCE NAME: HYDROCODONE BITARTRATE; GUAIFENESIN
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Opioid Agonist [EPC],Opioid Agonists [MoA]
ROUTE: ORAL
DOSAGE FORM: SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2014-12-30
END MARKETING DATE: 2018-06-30


OBREDON HUMAN PRESCRIPTION DRUG Details:

Item DescriptionOBREDON from NOVOTEC PHARMA LLC
LABELER NAME: NOVOTEC PHARMA LLC
DEA SCHEDULE: CII
ACTIVE STRENGTH: 2.5; 200(mg/5mL; mg/5mL)
START MARKETING DATE: 2014-12-30
END MARKETING DATE: 2018-06-30
PRODUCT ID: 69166-523_5b21dbc4-23fe-1d3b-e053-2a91aa0adfef
PRODUCT NDC: 69166-523
APPLICATION NUMBER: NDA205474

Other HYDROCODONE BITARTRATE; GUAIFENESIN Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
NOVOTEC PHARMA LLCOBREDON